Literature DB >> 20515787

Identification and characterization of the promoter of fibroblast activation protein.

Jiping Zhang1, Matthildi Valianou, Jonathan D Cheng.   

Abstract

Fibroblast activation protein (FAP) is a type II integral membrane glycoprotein belonging to the serine protease family. It is selectively expressed by tumor stromal fibroblasts and transiently in the fibroblasts of healing wounds. FAP has been shown to modulate growth, differentiation, adhesion, and metastasis of tumor cells. Despite the importance of FAP in cancer, the mechanisms that govern its expression have not been defined. In this study, we determined the transcription start site of the FAP gene and identified a 2-kb segment with promoter activity in cells expressing FAP. Truncation of this fragment revealed that the core promoter activity resided in a 245-bp fragment surrounding the transcription start site. Electrophoretic mobility shift assay showed that EGR1 binds to the FAP promoter. Mutation of the EGR1 site within this fragment significantly decreased the promoter activity of FAP and eliminated EGR1 binding. Down-regulation of EGR1 resulted in a significant reduction in endogenous FAP mRNA expression. These findings identify the basal transcriptional requirements of FAP gene expression and show EGR1 is an important regulator of FAP expression.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20515787      PMCID: PMC2880831          DOI: 10.2741/e175

Source DB:  PubMed          Journal:  Front Biosci (Elite Ed)        ISSN: 1945-0494


  39 in total

Review 1.  Early growth response-1 in cardiovascular pathobiology.

Authors:  Levon M Khachigian
Journal:  Circ Res       Date:  2006-02-03       Impact factor: 17.367

2.  Fibroblast activation protein increases apoptosis, cell adhesion, and migration by the LX-2 human stellate cell line.

Authors:  Xin Maggie Wang; Denise Ming Tse Yu; Geoffrey W McCaughan; Mark D Gorrell
Journal:  Hepatology       Date:  2005-10       Impact factor: 17.425

Review 3.  The transcription factor Egr1 is a direct regulator of multiple tumor suppressors including TGFbeta1, PTEN, p53, and fibronectin.

Authors:  V Baron; E D Adamson; A Calogero; G Ragona; D Mercola
Journal:  Cancer Gene Ther       Date:  2006-02       Impact factor: 5.987

4.  Molecular proximity of seprase and the urokinase-type plasminogen activator receptor on malignant melanoma cell membranes: dependence on beta1 integrins and the cytoskeleton.

Authors:  Vira V Artym; Andrei L Kindzelskii; Wen-Tien Chen; Howard R Petty
Journal:  Carcinogenesis       Date:  2002-10       Impact factor: 4.944

5.  Reactive stroma in human prostate cancer: induction of myofibroblast phenotype and extracellular matrix remodeling.

Authors:  Jennifer A Tuxhorn; Gustavo E Ayala; Megan J Smith; Vincent C Smith; Truong D Dang; David R Rowley
Journal:  Clin Cancer Res       Date:  2002-09       Impact factor: 12.531

6.  Seprase promotes rapid tumor growth and increased microvessel density in a mouse model of human breast cancer.

Authors:  Yan Huang; Sophie Wang; Thomas Kelly
Journal:  Cancer Res       Date:  2004-04-15       Impact factor: 12.701

7.  Cell-surface glycoproteins of human sarcomas: differential expression in normal and malignant tissues and cultured cells.

Authors:  W J Rettig; P Garin-Chesa; H R Beresford; H F Oettgen; M R Melamed; L J Old
Journal:  Proc Natl Acad Sci U S A       Date:  1988-05       Impact factor: 11.205

8.  Fibroblast activation protein: purification, epitope mapping and induction by growth factors.

Authors:  W J Rettig; S L Su; S R Fortunato; M J Scanlan; B K Raj; P Garin-Chesa; J H Healey; L J Old
Journal:  Int J Cancer       Date:  1994-08-01       Impact factor: 7.396

9.  Promotion of tumor growth by murine fibroblast activation protein, a serine protease, in an animal model.

Authors:  Jonathan D Cheng; Roland L Dunbrack; Matthildi Valianou; André Rogatko; R Katherine Alpaugh; Louis M Weiner
Journal:  Cancer Res       Date:  2002-08-15       Impact factor: 12.701

10.  Differential expression of cell surface antigens and glial fibrillary acidic protein in human astrocytoma subsets.

Authors:  W J Rettig; P G Chesa; H R Beresford; H J Feickert; M T Jennings; J Cohen; H F Oettgen; L J Old
Journal:  Cancer Res       Date:  1986-12       Impact factor: 12.701

View more
  12 in total

Review 1.  Tumors as organs: biologically augmenting radiation therapy by inhibiting transforming growth factor β activity in carcinomas.

Authors:  Shisuo Du; Mary Helen Barcellos-Hoff
Journal:  Semin Radiat Oncol       Date:  2013-10       Impact factor: 5.934

Review 2.  Rationale behind targeting fibroblast activation protein-expressing carcinoma-associated fibroblasts as a novel chemotherapeutic strategy.

Authors:  W Nathaniel Brennen; John T Isaacs; Samuel R Denmeade
Journal:  Mol Cancer Ther       Date:  2012-02       Impact factor: 6.261

3.  The role of fibroblast activation protein in progression and development of osteosarcoma cells.

Authors:  Liang Zhang; Li Yang; Zi-Wei Xia; Shi-Chang Yang; Wen-Hui Li; Bin Liu; Zi-Qi Yu; Peng-Fei Gong; Ya-Lin Yang; Wei-Zong Sun; Jing Mo; Gui-Shi Li; Tian-Yi Wang; Kai Wang
Journal:  Clin Exp Med       Date:  2019-11-19       Impact factor: 3.984

4.  Transcriptional regulation of seprase in invasive melanoma cells by transforming growth factor-β signaling.

Authors:  Shaun Tulley; Wen-Tien Chen
Journal:  J Biol Chem       Date:  2014-04-13       Impact factor: 5.157

5.  The Role of Proteomics in the Diagnosis and Treatment of Women's Cancers: Current Trends in Technology and Future Opportunities.

Authors:  Eun-Kyoung Yim Breuer; Mandi M Murph
Journal:  Int J Proteomics       Date:  2011-01-01

Review 6.  Fibroblast activation protein α in tumor microenvironment: recent progression and implications (review).

Authors:  Fuming Zi; Jingsong He; Donghua He; Yi Li; Li Yang; Zhen Cai
Journal:  Mol Med Rep       Date:  2015-01-14       Impact factor: 2.952

7.  Circulating fibroblast activation protein activity and antigen levels correlate strongly when measured in liver disease and coronary heart disease.

Authors:  Shirley Uitte de Willige; Fiona M Keane; David G Bowen; Joyce J M C Malfliet; H Emma Zhang; Bharvi Maneck; Geoffrey W McCaughan; Frank W G Leebeek; Dingeman C Rijken; Mark D Gorrell
Journal:  PLoS One       Date:  2017-06-05       Impact factor: 3.240

8.  Dental Tissue and Stem Cells Revisited: New Insights From the Expression of Fibroblast Activation Protein-Alpha.

Authors:  Ronald B Driesen; Petra Hilkens; Nick Smisdom; Tim Vangansewinkel; Yörg Dillen; Jessica Ratajczak; Esther Wolfs; Pascal Gervois; Marcel Ameloot; Annelies Bronckaers; Ivo Lambrichts
Journal:  Front Cell Dev Biol       Date:  2020-01-21

9.  Macrophages are exploited from an innate wound healing response to facilitate cancer metastasis.

Authors:  Tamara Muliaditan; Jonathan Caron; Mary Okesola; James W Opzoomer; Paris Kosti; Mirella Georgouli; Peter Gordon; Sharanpreet Lall; Desislava M Kuzeva; Luisa Pedro; Jacqueline D Shields; Cheryl E Gillett; Sandra S Diebold; Victoria Sanz-Moreno; Tony Ng; Esther Hoste; James N Arnold
Journal:  Nat Commun       Date:  2018-07-27       Impact factor: 14.919

Review 10.  Targeting of activated fibroblasts for imaging and therapy.

Authors:  Thomas Lindner; Anastasia Loktev; Frederik Giesel; Clemens Kratochwil; Annette Altmann; Uwe Haberkorn
Journal:  EJNMMI Radiopharm Chem       Date:  2019-07-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.